Medical Devices Startups

Vetbiolix develops first-in-class therapeutic drugs for companion animals, specifically targeting osteoarthritis, periodontitis, and gut motility disorders in dogs and cats. The company adapts promising drug candidates from human clinical development stages to the veterinary market.

1 investor

A veterinary pharmaceutical company developing Rabacfosadine, an acyclic nucleotide analogue for treating lymphoma in dogs and cats.

1 investor

Vetspire offers a real-time scheduling and workflow management tool designed for veterinary clinics. The platform enables drag-and-drop appointment scheduling, custom templates, and room assignment to streamline daily operations in veterinary practices.

1 investor

VFlow21 develops next-generation vascular stents and a patent-protected delivery system for brain endovascular treatments across arterial and venous applications. The company was established in 2021 and has been granted funding by the Israel Innovation Authority.

1 investor

ViaLase develops the ViaLase Laser System, a femtosecond laser and HD imaging platform for noninvasive interventional glaucoma treatment that creates apertures through the trabecular meshwork in patients with open-angle glaucoma. The technology, used via its FLigHT procedure, is aimed at ophthalmic surgeons treating glaucoma without incisional surgery.

1 investor

VIAN Therapeutics develops a topical eye drop treatment for retinal diseases caused by angiogenesis and vascular permeability, offering a non-invasive alternative to intravitreal injections. The lead candidate targets age-related macular degeneration and diabetic macular edema by inhibiting pro-angiogenic factors and inflammatory cytokines.

1 investor

VIBRAINT develops RehUp, a brain-controlled rehabilitation robot that uses a brain-computer interface and multisensory feedback to help patients paralyzed by stroke or spinal cord injury regain motor control. It targets clinical rehabilitation, with clinical and research partnerships in Canada and the US.

1 investor

Vibrato Medical develops wearable therapeutic ultrasound devices for treating peripheral artery disease. The company focuses on bringing medical device technology from development through clinical trials and regulatory approval.

1 investor

Vibronix develops medical diagnostic and treatment technology that combines vibrational spectroscopic imaging, optical and acoustic sensing, and machine learning for precision healthcare applications.

1 investor

Vicore Pharma is a clinical-stage biopharmaceutical company developing disease-modifying treatments for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis. The company's lead program, buloxibutid, is an oral small molecule in Phase 2b clinical trials.

1 investor

Safetest develops, produces, and sells rapid lateral-flow diagnostic test kits for detecting human diseases through isolation of specific antigens, and offers R&D, antigen/antibody conjugation services, training, and technical support. It positions itself as a Brazilian company making fully domestically produced rapid diagnostic tests for researchers, companies, and healthcare applications.

1 investor

VIDA provides AI-powered imaging biomarkers and clinical trial imaging services, using its VIDA Intelligence Platform to collect and analyze imaging data across respiratory, cardiovascular, oncology, and other therapeutic areas. It serves drug developers and clinical trial sponsors in the life sciences industry with quantitative image analysis, expert reading services, and digital biobank capabilities.

1 investor

Vidcare provides chronic disease management solutions through rapid testing and clinical tools designed to reduce repeat doctor visits and improve healthcare provider efficiency.

1 investor

BihlerMed manufactures LED surgical lights and provides contract manufacturing and design services for medical devices, including prototyping, engineering, and regulatory compliance support. The company operates a state-of-the-art facility in Phillipsburg, New Jersey and serves medical device manufacturers and practitioners.

1 investor

Vieworks develops imaging technology including machine vision cameras, high-speed CoaXPress-over-fiber solutions, X-ray detectors, radiography acquisition software, and digital pathology scanners. Its products serve industrial machine vision, medical radiography, and pathology markets.

1 investor

1 investor

Vilje Bionics develops VilPower, a motorized full-arm orthosis (exoskeleton) that supports movement in the shoulder, elbow, wrist, and grip for people with reduced arm function, such as stroke survivors and those with neurological conditions. The device reads and amplifies the user's remaining movements without invasive sensors, helping them perform daily tasks more independently.

1 investor

Vine Medical develops soft robotic medical devices designed to enhance clinician safety and outcomes during procedures. Their initial product, the Origin Intubation System, is a soft robot that guides airway navigation with a design that makes safe actions the default without relying on software.

1 investor

Viralgen provides contract manufacturing services for AAV-based gene therapy, supporting early-phase preclinical and clinical production with a platform designed for regulatory compliance and batch scalability. The company serves gene therapy developers pursuing treatments for rare diseases.

1 investor

Virchu operates a histopathology-powered precision oncology platform that aggregates de-identified whole-slide images and longitudinal patient data to train and validate AI models for cancer detection and treatment. The platform serves oncology researchers and AI developers seeking curated, representative data across multiple cancer types.

1 investor

Virilitas Labs develops research-led technologies focused on male fertility and reproductive health, drawing on over 20 years of study in reproduction and genetics. It aims to translate scientific research into products supporting couples with male infertility challenges.

1 investor

Virility Medical develops products and services for sexual wellness using medical technology and clinical research. The company serves individuals seeking science-based intimate health solutions.

1 investor

VirtaMed develops high-fidelity virtual reality surgical simulators for medical training across multiple specialties including orthopedics, laparoscopy, robotic surgery, gynecology, and urology. The simulators use original surgical instruments and provide realistic anatomy to help healthcare professionals accelerate competency development in a risk-free environment.

1 investor

Virtual POCT provides consulting services for Point-of-Care Testing (POCT) programs, including virtual team management, business development, market research, vendor selection, and facility assessments. It also helps healthcare organizations integrate AI diagnostics, build quality management systems, and meet regulatory compliance through risk assessments and validation protocols.

1 investor